Results 131 to 140 of about 40,797 (259)

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery [PDF]

, 2015
To perform a meta-analysis investigating venous thromboembolism (VTE) following isolated foot and ankle surgery and propose guidelines for VTE prevention in this group of patients.
Ackermann, PW, Calder, JD, Domeij-Arverud, E, Freeman, R, Van Dijk, CN   +4 more
core   +1 more source

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

New England Journal of Medicine, 2018
Background Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. Methods In this randomized,
A. Spyropoulos, W. Ageno, G. Albers, G. Elliott, J. Halperin, W. Hiatt, G. Maynard, G. Steg, J. Weitz, E. Suh, T. Spiro, E. Barnathan, G. Raskob   +12 more
semanticscholar   +1 more source

A Retrospective Study of Adult and Pediatric D‐Dimer Tests to Identify Opportunities for Improved Utilization

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction D‐dimers are produced by lysis of cross‐linked fibrin. In children, D‐dimer testing is used to evaluate disseminated intravascular coagulation (DIC) and some inflammatory states, but its use is not validated for screening or ruling out suspected venous thromboembolic events (VTE).
Rabab Al Dawood, Hassan Abu Sabah, Natalie Mathews, James Douketis, Catherine Hayward   +4 more
wiley   +1 more source

Variations in Perioperative Thromboprophylaxis Practices: Do the Guidelines Need a Closer Look?

Annals of Thoracic Surgery Short Reports
Background: In 2022, the American Association for Thoracic Surgery (AATS) and the European Society of Thoracic Surgeons (ESTS) published joint guidelines regarding the timing, duration, and choice of agent for perioperative venous thromboembolism ...
Russell Seth Martins, MD, Elizabeth Christophel, BS, Kostantinos Poulikidis, MD, Syed Shahzad Razi, MD, M. Jawad Latif, MD, Jeffrey Luo, PhD, Faiz Y. Bhora, MD   +6 more
doaj   +1 more source

Venous Thromboembolism Risk Assessment Among Ambulatory Cancer Patients: Demographic Study and Doctor's Adherence to Guidelines [PDF]

Al-Anbar Medical Journal
Background: Cancer-associated thrombosis (CAT) is the second cause of death for cancer patients. National Comprehensive Cancer Network (NCCN) guidelines recommend assessing CAT risk for all ambulatory cancer patients by Khorana score and prescribing ...
Marwa Tariq, Ehab Mikhael
doaj   +1 more source

Hypoxic Cell Waves around Necrotic Cores in Glioblastoma: A Biomathematical Model and its Therapeutic Implications

, 2012
Glioblastoma is a rapidly evolving high-grade astrocytoma that is distinguished pathologically from lower grade gliomas by the presence of necrosis and microvascular hiperplasia.
Calvo, Gabriel F., Martínez-González, Alicia, Pérez-García, Víctor M., Romasanta, Luis A. Pérez   +3 more
core   +1 more source

Thromboembolism in the Sub-Acute Phase of Spinal Cord Injury: A Systematic Review of the Literature. [PDF]

, 2016
To review the evidence of thromboembolism incidence and prophylaxis in the sub-acute phase of spinal cord injury (SCI) 3-6 months post injury. All observational and experimental studies with any length of follow-up and no limitations on language or ...
Alabed, Chung, Douma, El Masri, Frisbie, Geerts, Haisma, Kim, Klok, Lamb, Lee, Mackiewicz-Milewska, McKinley, Oger, Perkash, Riklin, Rossi, Saraf, Silver, Spencer, Stein, Teasell, Todd, Walsh   +23 more
core   +2 more sources

Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis

Hämostaseologie, 2020
The novel coronavirus, SARS-CoV-2, is causing a global pandemic of life-threatening multiorgan disease, called COVID-19. Accumulating evidence indicates that patients with COVID-19 are at significant risk of thromboembolic complications, mainly affecting
F. Langer, S. Kluge, R. Klamroth, J. Oldenburg   +3 more
semanticscholar   +1 more source

Considerations for Menstrual Suppression in Patients With Hematologic Malignancies

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 3, March 2026.
ABSTRACT Patients who menstruate during treatment for hematologic malignancies have a higher risk of heavy vaginal bleeding due to thrombocytopenia caused by malignancy and myelosuppressive chemotherapy. Heavy menstrual bleeding is associated with significant morbidity in this patient population, and menstrual suppression is a standard of supportive ...
Sahaana Veeravalli, Allison Schepers, Lydia L. Benitez, Martina S. Fraga   +3 more
wiley   +1 more source